- Pierre-Victor D
- Parnes HL
- Andriole GL
- Pinsky PF
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Prostate cancer incidence and mortality following a negative biopsy in a population undergoing PSA screening.Urology. 2021; (Published online June)https://doi.org/10.1016/j.urology.2021.05.060
- Prognostic significance of a negative prostate biopsy: an analysis of subjects enrolled in a prostate cancer screening trial.J Urol. 2017; 197: 1014-1019https://doi.org/10.1016/j.juro.2016.11.002
Funding support: The work presented here was not directly funded by an outside organization or sponsor. JES is supported by the The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust, Vinney Scholars Award, and a Damon Runyon Cancer Research Foundation Physician Scientist Training Award. SV is supported by the Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust and the Ferdinand C. Valentine Fellowship Award from the New York Academy of Medicine.